Corpus Intelligence IC Memo — ASPIRUS STEVENS POINT HOSPITAL 2026-04-26 09:06 UTC
IC Memo — ASPIRUS STEVENS POINT HOSPITAL
Investment Committee Memorandum | WI | 82 beds | Grade C | EBITDA uplift $14.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ASPIRUS STEVENS POINT HOSPITAL

CCN 520002 | PORTAGE, WI | 82 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ASPIRUS STEVENS POINT HOSPITAL is a 82-bed suburban community hospital in PORTAGE, WI with $201.4M in net patient revenue and a 28.9% operating margin. The hospital serves a payer mix of 26.0% Medicare, 6.9% Medicaid, and 67.1% commercial.

Thesis: Turnaround. Our ML models identify $14.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 28.9% to 36.2% (+736bps).

Net Revenue HCRIS$201.4M
Current EBITDA COMPUTED$58.1M
Operating Margin COMPUTED28.9%
Occupancy HCRIS39.6%
Revenue / Bed COMPUTED$2.5M
Net-to-Gross HCRIS42.3%
Distress Probability ML50.6%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
42
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 28.9% places it above the state median. Among 42 size-comparable peers (41-164 beds), the median margin is -4.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (41-164), prioritizing same-state peers. 42 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ASPIRUS STEVENS POINT HOSPITAL (Target)WI82$201.4M28.9%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
MCHS FRANCISCAN HEALTHCARE INWI103$413.8M-7.2%
AURORA MEDICAL CENTER KENOSHAWI151$304.2M13.8%
AURORA MEDICAL CENTER GRAFTONWI132$300.4M16.7%
ST. AGNES HOSPITALWI77$275.9M-3.0%
BELOIT MEMORIAL HOSPITAL INC.WI97$249.6M-3.0%
THEDACARE REGIONAL MEDICAL CENWI139$247.3M5.1%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.5M+122bp9mo
Clean Claim Rate88.0%96.0%$129K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.5M
Clean Claim Rate
$129K
Total EBITDA Uplift$14.8M
Current EBITDA$58.1M
+ RCM Uplift+$14.8M
Pro Forma EBITDA$72.9M
Current Margin28.9%
Pro Forma Margin36.2%
WC Released (1x)$7.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$89.4M$531.6M5.95x42.8%
Base (11x exit)10.0x11.0x$89.4M$613.8M6.87x47.0%
Bull Case9.0x11.0x$80.5M$691.8M8.60x53.8%
Bull (12x exit)9.0x12.0x$80.5M$778.5M9.67x57.4%
Bear Case11.0x10.0x$98.4M$428.5M4.36x34.2%
Bear (11x exit)11.0x11.0x$98.4M$503.3M5.12x38.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 42 hospitals with 41-164 beds
  • Same-state prioritization (n=43)
  • Comp margins: P25=-17.3% / P50=-4.4% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.